Navigation Links
Treatment to benefit African infants at risk of endemic fever
Date:4/22/2012

Thousands of pre-school children in Africa could benefit from access to treatment for an endemic disease, after tests showed infants to be at high risk of infection.

Researchers tested hundreds of children aged between one and five in countries in sub-Saharan Africa where snail fever also known as bilharzia or schistosomiasis is endemic. Currently, infants are not regularly tested for infection as they are perceived to be at low risk of exposure to the water-borne disease and not to suffer severely from its ill-effects.

Scientists showed that in fact, infection rates are high among pre-school children. This may be because they often accompany their mothers to rivers and wells. Symptoms of the disease which can include impaired memory and thought as well as damage to internal organs and stunted growth are not always obvious.

The study found that a common snail fever drug, known as praziquantel, which is regularly given to older children and adults, can safely cure the infection in infants. The treatment is cheap and effective, curing infection and stopping progress of disease in a single dose.

Researchers from the University of Edinburgh carried out studies in Zimbabwe and their results were combined with work by other teams in Mali, Sudan, Egypt, Niger and Uganda. In a recent World Health Organisation report, the teams recommended that infants be included in treatment programmes, and their work is informing public health policy.

According to the WHO, snail fever affects 230 million people each year, most of whom are African. Some 33.5 million people were treated for the disease in 2010. Children are especially vulnerable because they make frequent contact with infected water.

Dr Francisca Mutapi, of the University of Edinburgh's School of Biological Sciences, who took part in the study, said: "Snail fever is a widespread disease of major health consequence in young children. Our study shows that infants are especially vulnerable to infection and should be included in public health treatment programmes."


'/>"/>

Contact: Catriona Kelly
catriona.kelly@ed.ac.uk
44-131-651-4401
University of Edinburgh
Source:Eurekalert

Related biology news :

1. Drug interactions wont exclude HCV transplant or HIV co-infected patients from treatment
2. As deadly cat disease spreads nationally, MU veterinarian finds effective treatment
3. Promising developments in early diagnosis and treatment of mesothelioma
4. Antipsychotic drug may be helpful treatment for anorexia nervosa
5. New discovery may lead to effective prevention and treatment of graft-versus-host dsease
6. Researcher who identifed genetic cause and possible treatment for Marfan syndrome honored
7. Penn research points to new way of preserving fertility for boys undergoing cancer treatment
8. Minimally invasive treatment for ruptured aneurysm: Safe, reduces mortality
9. New discoveries about brain-hand connection sought to improve therapies, treatments, prosthetics
10. Marshall University study may lead to new treatments for prostate cancer
11. Step forward in research into new treatments for brain edema
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... Feb. 7, 2017 Report Highlights ... The global synthetic-biology market ... billion by 2021, growing at a compound annual growth rate ... overview of the global markets for synthetic biology. - Analyses ... 2016, and projections of compound annual growth rates (CAGRs) through ...
(Date:2/7/2017)... BEACH, New York , February 7, 2017 /PRNewswire/ ... known as ID Global Solutions Corporation [OTC: IDGS], ("Ipsidy" ... identity management and electronic transaction processing services, is pleased ... reorganization of the Company. Effective January 31, ... of the Board of Directors, CEO and President.  An ...
(Date:2/2/2017)... , Feb. 2, 2017  EyeLock LLC, a ... a new white paper " What You Should Know ... problem of ensuring user authenticity is a growing concern. ... authentication of users. However, traditional authentication schemes such as ... Biometric authentication offers an elegant solution to ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... Pa., Feb. 24, 2017  VWR Corporation (NASDAQ: VWR), the ... laboratory and production customers, today reported its financial results for ... Highlights: 4Q16 record quarterly ... 1.0% on an organic basis. ... an organic basis, while the Americas net sales increased 2.5%, ...
(Date:2/23/2017)... LONDON and NEW YORK ... at HIMSS, Lumeon , a leading digital ... (DN Telehealth), a provider of telemedicine and remote ... care pathways for telemedicine reimbursements.  ... and their patients, in real-time, extending consultations beyond ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... ... Drug Discovery Services portfolio to include an array of biochemical analyses critical ... reliable data to drive their hit-to-lead and SAR programs, including inhibitor potency and ...
(Date:2/23/2017)... 2017  MIODx announced today that it has ... technologies from the University of California, San Francisco ... monitor a patient for response to immune checkpoint ... second license extends the technology with a method ... have an immune-related adverse event (IRAE) from their ...
Breaking Biology Technology: